Category: biotech

.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer in 2014 for an enormous $43 billion, past CEO David Epstein stated he was

.Amidst the genetic medicines arms race, Flagship Pioneering is actually unveiling a brand-new firm to assist biotechs adjust the precision of their treatments.The project creation

.Fierce Biotech Partner Editor Gabrielle Masson provided the 2024 course of Fierce 15 winners on the flooring of the Stock exchange on Wednesday.Masson appeared on

.Permit’s dive into a talk with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as they cover the highlights as well as enthusiasm surrounding

.FibroGen is substantially reorganizing its own service, giving up 75% of its own united state workers and ceasing investment in its lead candidate in feedback

.After F2G’s first attempt to obtain a brand-new course of antifungal to market was hindered due to the FDA, the U.K.-based biotech has actually protected

.The FDA has put Kezar Lifestyle Sciences’ lupus trial on grip after the biotech flagged 4 fatalities in the course of the phase 2b research

.The FDA has actually applied a predisposed hang on a phase 3 non-small tissue bronchi cancer dry run through BioNTech and also OncoC4 after seeing

.After dismissing the decision date for Applied Therapeutics’ metabolic disorder medication govorestat, the FDA has now chosen that a considered consultatory board conference will not

.For Lykos Therapies as well as the firm’s would-be MDMA-assisted treatment for post-traumatic stress disorder (POST-TRAUMATIC STRESS DISORDER), the smash hits simply maintain happening..Earlier this